• Contagion LiveContagion Live
  • CGTLive logoCGTLive logo
  • HCP LiveHCP Live
  • Neurology Live
  • OncLiveOncLive
NeurologyLive – Clinical Neurology News and Neurology Expert Insights
NeurologyLive – Clinical Neurology News and Neurology Expert Insights
Spotlight
Future Leaders in NeurologyAAN 2022Remote Care for Movement Disorders
Clinical Focus
View MoreDementia/AlzheimerEpilepsyHeadache/MigraineMovement DisordersMultiple SclerosisNeuromuscularSleep MedicineStroke
Video Series
Cure ConnectionsInsightsNeurologyLive Peer ExchangeNews Network
News
Media
All Videos
Medical World News
Podcasts
Weekly Recap
Cure Connections
Insights
News Network
NeurologyLive Peer Exchange
Conferences
Conference Coverage
Conference Listing
CME/CEPartners
Publications
NeurologyLive
International Journal of MS Care
Resources
Disease Spotlight
Fellows' Corner
Future Leaders in Neurology
Giants of Multiple Sclerosis
Interactive Tools
Live Events
Neurology Resources
Virtual Events
Subscribe
  • About Us
  • Advisory Board
  • Editorial
  • Contact Us
  • Advertise
  • Contact MJH LS
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy

© 2022 MJH Life Sciences and NeurologyLive – Clinical Neurology News and Neurology Expert Insights. All rights reserved.

Spotlight
  • Future Leaders in Neurology
  • AAN 2022
  • Remote Care for Movement Disorders
Clinical FocusSee All >
  • Dementia/Alzheimer
  • Epilepsy
  • Headache/Migraine
  • Movement Disorders
  • Multiple Sclerosis
  • Neuromuscular
  • Sleep Medicine
  • Stroke
Video Series
  • Cure Connections
  • Insights
  • NeurologyLive Peer Exchange
  • News Network
  • About Us
  • Advisory Board
  • Editorial
  • Contact Us
  • Advertise
  • Contact MJH LS
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ , NeurologyLive – Clinical Neurology News and Neurology Expert Insights. All rights reserved.

AAN 2020: Multiple Sclerosis Treatment Considerations

EP. 1: Multiple Sclerosis and Risk of COVID-19

May 22nd 2020

EP. 2: Disease-Modifying Therapies for MS During COVID-19

May 22nd 2020

EP. 3: AAN 2020: Real-World Data on Cladribine Tablets for MS

May 22nd 2020

EP. 4: Multiple Sclerosis: Takeaways From AAN 2020

May 22nd 2020

EP. 5: MS Treatment Optimization During COVID-19

May 22nd 2020

EP. 6: Treating Patients With MS During the COVID-19 Pandemic

May 22nd 2020

EP. 7: AAN 2020 Data Release: Ofatumumab for Relapsing MS

May 22nd 2020

EP. 8: Novel Oral Therapy for MS: AAN Data Updates

May 22nd 2020

EP. 9: The Future of Multiple Sclerosis Management

May 22nd 2020

Latest News

NeuroVoices: Michael Sughrue, MD, on the Future of Brain Mapping and Utilizing Advanced Technology

The Mobile Stroke Unit Paradigm Shift for EMS: Thomas Topley

American Stroke Association Publishes Updated Guidance for Intracerebral Hemorrhage

FDA Accepts New Drug Application for Intranasal Zavegepant to Treat Acute Migraine

View More News